CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models CXCR4 Inhibition Has Anti-Tumor and Anti-Metastatic Effects in Prostate Cancer Models
Saved in:
Published in | The Prostate Vol. 75; no. 12; pp. 1227 - 1246 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.07.2015
|
Online Access | Get full text |
Cover
Loading…
Author | Mattei, Claudia Biordi, Leda Pompili, Simona Ricevuto, Enrico Ventura, Luca Di Cesare, Ernesto Festuccia, Claudio Gravina, Giovanni Luca Muzi, Paola Jannini, Emmanuele A. Mancini, Andrea |
---|---|
Author_xml | – sequence: 1 givenname: Giovanni Luca surname: Gravina fullname: Gravina, Giovanni Luca organization: Division of Radiation Oncology; Department of Biotechnological and Applied Clinical Sciences; University of L'Aquila; L'Aquila Italy, Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy – sequence: 2 givenname: Andrea surname: Mancini fullname: Mancini, Andrea organization: Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy – sequence: 3 givenname: Paola surname: Muzi fullname: Muzi, Paola organization: Department of Life; Health and Environmental Sciences; L'Aquila Italy – sequence: 4 givenname: Luca surname: Ventura fullname: Ventura, Luca organization: Pathology Department; San Salvatore Hospital L'Aquila; L'Aquila Italy – sequence: 5 givenname: Leda surname: Biordi fullname: Biordi, Leda organization: Department of Biotechnological and Applied Clinical Sciences; Laboratory of Molecular Pathology; University of L'Aquila; L'Aquila Italy – sequence: 6 givenname: Enrico surname: Ricevuto fullname: Ricevuto, Enrico organization: Department of Biotechnological and Applied Clinical Sciences; Laboratory of Molecular Pathology; University of L'Aquila; L'Aquila Italy – sequence: 7 givenname: Simona surname: Pompili fullname: Pompili, Simona organization: Department of Biotechnological and Applied Clinical Sciences; Laboratory of Human Anatomy; L'Aquila Italy – sequence: 8 givenname: Claudia surname: Mattei fullname: Mattei, Claudia organization: Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy – sequence: 9 givenname: Ernesto surname: Di Cesare fullname: Di Cesare, Ernesto organization: Division of Radiation Oncology; Department of Biotechnological and Applied Clinical Sciences; University of L'Aquila; L'Aquila Italy, Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy – sequence: 10 givenname: Emmanuele A. surname: Jannini fullname: Jannini, Emmanuele A. organization: Department of Systems Medicine; University of Tor Vergata; Roma Italy – sequence: 11 givenname: Claudio surname: Festuccia fullname: Festuccia, Claudio organization: Department of Biotechnological and Applied Clinical Sciences; Laboratory of Radiobiology; University of L'Aquila; L'Aquila Italy |
BookMark | eNqVj0FOw0AMRWdRJFpg0xN4jdTiJJVygKiINWLBLppMnMQo8UQzjlBPxDWZRFyAlWXrv-__D2YnXsiYY4bnDDF_mYOP57xALHdmj3mJp0tWlPfmEOMXYpJgvjc_1Wf1foF5sGGyzvfs7AgsAzes7AUCtYujCE3yBistRN8pKMe4EEykNqpVdtAsoSWB5ga268gpSw-6TD5AH_y3Dhu7HbgnScDslUR5-wZr1ORD4Kw4CmknN7JsYSbf0hgfzV1nx0hPf_PBPL9eP6q3k0toDNTVc-DJhludYb3Wr1fPeqtf_Ev8C6YDawQ |
Cites_doi | 10.3748/wjg.v17.i19.2389 10.1158/1541-7786.MCR-07-0117 10.1677/erc.1.01100 10.1042/CBI20100744 10.1006/excr.2002.5609 10.1186/1476-4598-5-56 10.1002/pros.21008 10.1016/j.ejca.2010.09.028 10.1677/ERC-07-0118 10.1016/j.oraloncology.2012.01.006 10.1593/neo.12324 10.2741/2311 10.1158/1078-0432.CCR-05-2050 10.1002/path.2908 10.1038/6495 10.1158/1078-0432.CCR-05-1671 10.1359/JBMR.041109 10.1182/blood-2008-06-162123 10.1186/1471-2490-14-12 10.1002/pros.1065 10.1158/1541-7786.MCR-13-0029-T 10.1093/jnci/85.5.394 10.1007/s00418-012-0998-0 10.1002/pros.10290 10.1016/j.ejca.2009.12.014 10.1111/j.1349-7006.2007.00712.x 10.1371/journal.pone.0047287 10.1038/onc.2009.298 10.1016/j.urolonc.2007.05.010 10.1096/fj.03-0935fje 10.2174/138161210794455003 10.1016/S0959-8049(00)00436-6 10.3892/ijo.2013.1892 10.1007/s12032-013-0674-9 10.3892/or.2012.2028 10.1002/pros.21140 10.1002/pros.20500 10.1186/1756-8722-7-46 10.1002/pros.20318 10.1182/blood-2011-10-383406 10.1593/neo.05694 10.1016/j.ejca.2011.05.006 10.1016/j.ejca.2006.06.024 10.1530/ERC-11-0045 10.2174/092986711797287539 10.1111/j.1349-7006.2012.02200.x 10.1016/j.jss.2008.06.044 10.1158/0008-5472.CAN-04-1844 10.1016/j.ejcb.2012.04.005 10.4161/cam.21559 10.1158/0008-5472.CAN-10-1146 10.1016/j.jss.2012.09.035 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1002/pros.23007 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 1246 |
ExternalDocumentID | 10_1002_pros_23007 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAYXX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CITATION CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT |
ID | FETCH-crossref_primary_10_1002_pros_230073 |
ISSN | 0270-4137 |
IngestDate | Fri Aug 23 02:11:38 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1002_pros_230073 |
ParticipantIDs | crossref_primary_10_1002_pros_23007 |
PublicationCentury | 2000 |
PublicationDate | 2015-07-00 |
PublicationDateYYYYMMDD | 2015-07-01 |
PublicationDate_xml | – month: 07 year: 2015 text: 2015-07-00 |
PublicationDecade | 2010 |
PublicationTitle | The Prostate |
PublicationYear | 2015 |
References | Domanska UM1 (10.1002/pros.23007-BIB0055|pros23007-cit-0055) 2012; 14 van Bokhoven (10.1002/pros.23007-BIB0047|pros23007-cit-0047) 2003; 57 Festuccia (10.1002/pros.23007-BIB0050|pros23007-cit-0050) 1995; 7 Schulte (10.1002/pros.23007-BIB0067|pros23007-cit-0067) 2012; 138 Li (10.1002/pros.23007-BIB0019|pros23007-cit-0019) 2012; 48 Angelucci (10.1002/pros.23007-BIB0048|pros23007-cit-0048) 2006; 42 Ye (10.1002/pros.23007-BIB0002|pros23007-cit-0002) 2007; 2 Festuccia (10.1002/pros.23007-BIB0007|pros23007-cit-0007) 1999; 11 Wong (10.1002/pros.23007-BIB0037|pros23007-cit-0037) 2014; 14 Angelucci (10.1002/pros.23007-BIB0039|pros23007-cit-0039) 2006; 13 Feng (10.1002/pros.23007-BIB0025|pros23007-cit-0025) 2011; 47 Huang (10.1002/pros.23007-BIB0030|pros23007-cit-0030) 2009; 155 Zhao (10.1002/pros.23007-BIB0033|pros23007-cit-0033) 2011; 17 Festuccia (10.1002/pros.23007-BIB0009|pros23007-cit-0009) 1997; 9 Festuccia (10.1002/pros.23007-BIB0051|pros23007-cit-0051) 2007; 14 Yu (10.1002/pros.23007-BIB0068|pros23007-cit-0068) 2013; 30 Hasegawa (10.1002/pros.23007-BIB0058|pros23007-cit-0058) 2012; 30 Lee (10.1002/pros.23007-BIB0056|pros23007-cit-0056) 2010; 29 Perez (10.1002/pros.23007-BIB0008|pros23007-cit-0008) 2001; 37 Darash-Yahana (10.1002/pros.23007-BIB0010|pros23007-cit-0010) 2004; 18 Angelucci (10.1002/pros.23007-BIB0038|pros23007-cit-0038) 2004; 25 Hadaschik (10.1002/pros.23007-BIB0003|pros23007-cit-0003) 2007; 25 Ping (10.1002/pros.23007-BIB0017|pros23007-cit-0017) 2011; 224 Engl (10.1002/pros.23007-BIB0021|pros23007-cit-0021) 2006; 8 Porvasnik (10.1002/pros.23007-BIB0061|pros23007-cit-0061) 2009; 69 Drenckhan (10.1002/pros.23007-BIB0029|pros23007-cit-0029) 2013; 182 Smith (10.1002/pros.23007-BIB0011|pros23007-cit-0011) 2004; 64 Pan (10.1002/pros.23007-BIB0014|pros23007-cit-0014) 2006; 5 Chinni (10.1002/pros.23007-BIB0036|pros23007-cit-0036) 2008; 6 Wang (10.1002/pros.23007-BIB0018|pros23007-cit-0018) 2011; 35 Lin (10.1002/pros.23007-BIB0035|pros23007-cit-0035) 2010; 70 Craft (10.1002/pros.23007-BIB0042|pros23007-cit-0042) 1999; 5 Uy (10.1002/pros.23007-BIB0027|pros23007-cit-0027) 2012; 119 Lin (10.1002/pros.23007-BIB0041|pros23007-cit-0041) 2001; 47 Hatano (10.1002/pros.23007-BIB0066|pros23007-cit-0066) 2013; 11 Larsson (10.1002/pros.23007-BIB0004|pros23007-cit-0004) 2011; 18 Arya (10.1002/pros.23007-BIB0013|pros23007-cit-0013) 2004; 4 Akashi (10.1002/pros.23007-BIB0012|pros23007-cit-0012) 2008; 99 Liekens (10.1002/pros.23007-BIB0016|pros23007-cit-0016) 2010; 16 Chinni (10.1002/pros.23007-BIB0020|pros23007-cit-0020) 2006; 66 Pretlow (10.1002/pros.23007-BIB0043|pros23007-cit-0043) 1993; 85 Festuccia (10.1002/pros.23007-BIB0049|pros23007-cit-0049) 2002; 280 Uchida (10.1002/pros.23007-BIB0062|pros23007-cit-0062) 2011; 47 Sun (10.1002/pros.23007-BIB0063|pros23007-cit-0063) 2005; 20 Domanska (10.1002/pros.23007-BIB0028|pros23007-cit-0028) 2012; 14 Uchida (10.1002/pros.23007-BIB0032|pros23007-cit-0032) 2011; 47 Bruzzese (10.1002/pros.23007-BIB0053|pros23007-cit-0053) 2006; 12 Taichman (10.1002/pros.23007-BIB0015|pros23007-cit-0015) 2002; 62 Gravina (10.1002/pros.23007-BIB0052|pros23007-cit-0052) 2011; 18 Pettaway CA1 (10.1002/pros.23007-BIB0040|pros23007-cit-0040) 1996; 2 Ping (10.1002/pros.23007-BIB0057|pros23007-cit-0057) 2011; 224 Ferlay (10.1002/pros.23007-BIB0001|pros23007-cit-0001) 2010; 46 Wang (10.1002/pros.23007-BIB0024|pros23007-cit-0024) 2012; 28 Nervi (10.1002/pros.23007-BIB0026|pros23007-cit-0026) 2009; 113 Korenchuk (10.1002/pros.23007-BIB0044|pros23007-cit-0044) 2001; 15 Richert (10.1002/pros.23007-BIB0060|pros23007-cit-0060) 2009; 21 Addadi (10.1002/pros.23007-BIB0059|pros23007-cit-0059) 2010; 70 Gros (10.1002/pros.23007-BIB0034|pros23007-cit-0034) 2012; 7 Porvasnik (10.1002/pros.23007-BIB0065|pros23007-cit-0065) 2009; 69 Matsui (10.1002/pros.23007-BIB0023|pros23007-cit-0023) 2012; 103 Yamaguchi (10.1002/pros.23007-BIB0006|pros23007-cit-0006) 2012; 91 Yang (10.1002/pros.23007-BIB0054|pros23007-cit-0054) 2006; 12 Porvasnik (10.1002/pros.23007-BIB0031|pros23007-cit-0031) 2009; 69 Sun (10.1002/pros.23007-BIB0022|pros23007-cit-0022) 2007; 67 Bradbury (10.1002/pros.23007-BIB0005|pros23007-cit-0005) 2012; 6 Gravina (10.1002/pros.23007-BIB0045|pros23007-cit-0045) 2013; 42 Gravina (10.1002/pros.23007-BIB0046|pros23007-cit-0046) 2014; 7 Huang (10.1002/pros.23007-BIB0064|pros23007-cit-0064) 2009; 155 |
References_xml | – volume: 17 start-page: 2389 year: 2011 ident: 10.1002/pros.23007-BIB0033|pros23007-cit-0033 article-title: CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma publication-title: World J Gastroenterol doi: 10.3748/wjg.v17.i19.2389 contributor: fullname: Zhao – volume: 6 start-page: 446 year: 2008 ident: 10.1002/pros.23007-BIB0036|pros23007-cit-0036 article-title: CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone publication-title: Mol Cancer Res . doi: 10.1158/1541-7786.MCR-07-0117 contributor: fullname: Chinni – volume: 13 start-page: 197 year: 2006 ident: 10.1002/pros.23007-BIB0039|pros23007-cit-0039 article-title: Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice publication-title: Endocr Relat Cancer doi: 10.1677/erc.1.01100 contributor: fullname: Angelucci – volume: 15 start-page: 163 year: 2001 ident: 10.1002/pros.23007-BIB0044|pros23007-cit-0044 article-title: VCaP, a cell-based model system of human prostate cancer publication-title: In Vivo contributor: fullname: Korenchuk – volume: 25 start-page: 1713 year: 2004 ident: 10.1002/pros.23007-BIB0038|pros23007-cit-0038 article-title: Evaluation of metastatic potential in prostate carcinoma: An in vivo model publication-title: Int J Oncol contributor: fullname: Angelucci – volume: 35 start-page: 897 year: 2011 ident: 10.1002/pros.23007-BIB0018|pros23007-cit-0018 article-title: Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line publication-title: Cell Biol Int doi: 10.1042/CBI20100744 contributor: fullname: Wang – volume: 280 start-page: 1 year: 2002 ident: 10.1002/pros.23007-BIB0049|pros23007-cit-0049 article-title: Bombesindependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement publication-title: Exp Cell Res doi: 10.1006/excr.2002.5609 contributor: fullname: Festuccia – volume: 5 start-page: 56 year: 2006 ident: 10.1002/pros.23007-BIB0014|pros23007-cit-0014 article-title: Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis publication-title: Mol Cancer doi: 10.1186/1476-4598-5-56 contributor: fullname: Pan – volume: 69 start-page: 1460 year: 2009 ident: 10.1002/pros.23007-BIB0031|pros23007-cit-0031 article-title: Effects of CXCR4 antagonist CTCE-9908 on prostate tumour growth publication-title: Prostate doi: 10.1002/pros.21008 contributor: fullname: Porvasnik – volume: 47 start-page: 452 year: 2011 ident: 10.1002/pros.23007-BIB0032|pros23007-cit-0032 article-title: Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases publication-title: Eur J Cancer doi: 10.1016/j.ejca.2010.09.028 contributor: fullname: Uchida – volume: 14 start-page: 601 year: 2007 ident: 10.1002/pros.23007-BIB0051|pros23007-cit-0051 article-title: Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer publication-title: Endocr Relat Cancer doi: 10.1677/ERC-07-0118 contributor: fullname: Festuccia – volume: 62 start-page: 1832 year: 2002 ident: 10.1002/pros.23007-BIB0015|pros23007-cit-0015 article-title: Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone publication-title: Cancer Res contributor: fullname: Taichman – volume: 48 start-page: 507 year: 2012 ident: 10.1002/pros.23007-BIB0019|pros23007-cit-0019 article-title: The role of IL-8 in the SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2012.01.006 contributor: fullname: Li – volume: 14 start-page: 709 year: 2012 ident: 10.1002/pros.23007-BIB0055|pros23007-cit-0055 article-title: CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy publication-title: Neoplasia . doi: 10.1593/neo.12324 contributor: fullname: Domanska UM1 – volume: 2 start-page: 3273 year: 2007 ident: 10.1002/pros.23007-BIB0002|pros23007-cit-0002 article-title: Biology and clinical management of prostate cancer bone metastasis publication-title: Front Biosci doi: 10.2741/2311 contributor: fullname: Ye – volume: 12 start-page: 2602 year: 2006 ident: 10.1002/pros.23007-BIB0054|pros23007-cit-0054 article-title: The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-2050 contributor: fullname: Yang – volume: 224 start-page: 344 year: 2011 ident: 10.1002/pros.23007-BIB0017|pros23007-cit-0017 article-title: The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling publication-title: J Pathol doi: 10.1002/path.2908 contributor: fullname: Ping – volume: 5 start-page: 280 year: 1999 ident: 10.1002/pros.23007-BIB0042|pros23007-cit-0042 article-title: A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase publication-title: Nat Med doi: 10.1038/6495 contributor: fullname: Craft – volume: 12 start-page: 617 year: 2006 ident: 10.1002/pros.23007-BIB0053|pros23007-cit-0053 article-title: Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-1671 contributor: fullname: Bruzzese – volume: 20 start-page: 318 year: 2005 ident: 10.1002/pros.23007-BIB0063|pros23007-cit-0063 article-title: Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo publication-title: J Bone Miner Res doi: 10.1359/JBMR.041109 contributor: fullname: Sun – volume: 113 start-page: 6206 issue: 24 year: 2009 ident: 10.1002/pros.23007-BIB0026|pros23007-cit-0026 article-title: Mobilisation and chemosensitisation of AML with the CXCR4 antagonist plerixafor (AMD3100): A phase I/II study of AMD3100 + MEC in patients with relapsed or refractory disease publication-title: Blood doi: 10.1182/blood-2008-06-162123 contributor: fullname: Nervi – volume: 9 start-page: 419 year: 1997 ident: 10.1002/pros.23007-BIB0009|pros23007-cit-0009 article-title: Human prostatic tumour cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma publication-title: Oncol Res contributor: fullname: Festuccia – volume: 14 start-page: 12 year: 2014 ident: 10.1002/pros.23007-BIB0037|pros23007-cit-0037 article-title: Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis publication-title: BMC Urol doi: 10.1186/1471-2490-14-12 contributor: fullname: Wong – volume: 47 start-page: 212 year: 2001 ident: 10.1002/pros.23007-BIB0041|pros23007-cit-0041 article-title: Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro publication-title: Prostate doi: 10.1002/pros.1065 contributor: fullname: Lin – volume: 11 start-page: 1088 year: 2013 ident: 10.1002/pros.23007-BIB0066|pros23007-cit-0066 article-title: Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-13-0029-T contributor: fullname: Hatano – volume: 85 start-page: 394 year: 1993 ident: 10.1002/pros.23007-BIB0043|pros23007-cit-0043 article-title: Xenografts of primary human prostatic carcinoma publication-title: J Natl Cancer Inst doi: 10.1093/jnci/85.5.394 contributor: fullname: Pretlow – volume: 138 start-page: 847 year: 2012 ident: 10.1002/pros.23007-BIB0067|pros23007-cit-0067 article-title: Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: Relation to stromal fibroblast activation and invasive behaviour of carcinoma cells publication-title: Histochem Cell Biol doi: 10.1007/s00418-012-0998-0 contributor: fullname: Schulte – volume: 57 start-page: 205 year: 2003 ident: 10.1002/pros.23007-BIB0047|pros23007-cit-0047 article-title: Molecular characterization of human prostate carcinoma cell lines publication-title: Prostate doi: 10.1002/pros.10290 contributor: fullname: van Bokhoven – volume: 46 start-page: 765 year: 2010 ident: 10.1002/pros.23007-BIB0001|pros23007-cit-0001 article-title: Estimates of cancer incidence and mortality in Europe in 2008 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2009.12.014 contributor: fullname: Ferlay – volume: 99 start-page: 539 year: 2008 ident: 10.1002/pros.23007-BIB0012|pros23007-cit-0012 article-title: Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2007.00712.x contributor: fullname: Akashi – volume: 47 start-page: 452 year: 2011 ident: 10.1002/pros.23007-BIB0062|pros23007-cit-0062 article-title: Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases publication-title: Eur J Cancer doi: 10.1016/j.ejca.2010.09.028 contributor: fullname: Uchida – volume: 2 start-page: 1627 year: 1996 ident: 10.1002/pros.23007-BIB0040|pros23007-cit-0040 article-title: Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice publication-title: Clin Cancer Res contributor: fullname: Pettaway CA1 – volume: 7 start-page: 131 year: 1995 ident: 10.1002/pros.23007-BIB0050|pros23007-cit-0050 article-title: Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma publication-title: Oncol Res contributor: fullname: Festuccia – volume: 224 start-page: 344 year: 2011 ident: 10.1002/pros.23007-BIB0057|pros23007-cit-0057 article-title: The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling publication-title: J Pathol doi: 10.1002/path.2908 contributor: fullname: Ping – volume: 7 start-page: e47287 issue: 10 year: 2012 ident: 10.1002/pros.23007-BIB0034|pros23007-cit-0034 article-title: Involvement of CXCR4 chemokine receptor in metastatic HER2-positive oesophageal cancer publication-title: PLoS ONE doi: 10.1371/journal.pone.0047287 contributor: fullname: Gros – volume: 29 start-page: 56 year: 2010 ident: 10.1002/pros.23007-BIB0056|pros23007-cit-0056 article-title: PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression publication-title: Oncogene doi: 10.1038/onc.2009.298 contributor: fullname: Lee – volume: 69 start-page: 1460 year: 2009 ident: 10.1002/pros.23007-BIB0061|pros23007-cit-0061 article-title: Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth publication-title: Prostate doi: 10.1002/pros.21008 contributor: fullname: Porvasnik – volume: 25 start-page: 413 year: 2007 ident: 10.1002/pros.23007-BIB0003|pros23007-cit-0003 article-title: Therapeutic options for hormone-refractory prostate cancer in publication-title: Urol Oncol doi: 10.1016/j.urolonc.2007.05.010 contributor: fullname: Hadaschik – volume: 18 start-page: 1240 year: 2004 ident: 10.1002/pros.23007-BIB0010|pros23007-cit-0010 article-title: Role of high expression levels of CXCR4 in tumour growth, vascularisation, and metastasis publication-title: FASEB J doi: 10.1096/fj.03-0935fje contributor: fullname: Darash-Yahana – volume: 16 start-page: 3903 year: 2010 ident: 10.1002/pros.23007-BIB0016|pros23007-cit-0016 article-title: CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization publication-title: Curr Pharm Des doi: 10.2174/138161210794455003 contributor: fullname: Liekens – volume: 37 start-page: 629 year: 2001 ident: 10.1002/pros.23007-BIB0008|pros23007-cit-0008 article-title: Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines publication-title: Eur J Cancer doi: 10.1016/S0959-8049(00)00436-6 contributor: fullname: Perez – volume: 21 start-page: 761 year: 2009 ident: 10.1002/pros.23007-BIB0060|pros23007-cit-0060 article-title: Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone publication-title: Oncol Rep contributor: fullname: Richert – volume: 30 start-page: 35 year: 2012 ident: 10.1002/pros.23007-BIB0058|pros23007-cit-0058 article-title: Differential effects of TGF-β1 and FGF-2 on SDF-1α expression in human periodontal ligament cells derived from deciduous teeth in vitro publication-title: Int J Mol Med contributor: fullname: Hasegawa – volume: 42 start-page: 2116 year: 2013 ident: 10.1002/pros.23007-BIB0045|pros23007-cit-0045 article-title: Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples publication-title: Int J Oncol doi: 10.3892/ijo.2013.1892 contributor: fullname: Gravina – volume: 30 start-page: 674 year: 2013 ident: 10.1002/pros.23007-BIB0068|pros23007-cit-0068 article-title: Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion publication-title: Med Oncol doi: 10.1007/s12032-013-0674-9 contributor: fullname: Yu – volume: 28 start-page: 2043 year: 2012 ident: 10.1002/pros.23007-BIB0024|pros23007-cit-0024 article-title: Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells publication-title: Oncol Rep doi: 10.3892/or.2012.2028 contributor: fullname: Wang – volume: 70 start-page: 1066 year: 2010 ident: 10.1002/pros.23007-BIB0035|pros23007-cit-0035 article-title: Effects of transplantation of adipose tissue-derived stem cells on prostate tumour publication-title: Prostate doi: 10.1002/pros.21140 contributor: fullname: Lin – volume: 67 start-page: 61 year: 2007 ident: 10.1002/pros.23007-BIB0022|pros23007-cit-0022 article-title: Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells publication-title: Prostate doi: 10.1002/pros.20500 contributor: fullname: Sun – volume: 7 start-page: 46 year: 2014 ident: 10.1002/pros.23007-BIB0046|pros23007-cit-0046 article-title: XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa) publication-title: J Hematol Oncol doi: 10.1186/1756-8722-7-46 contributor: fullname: Gravina – volume: 66 start-page: 32 year: 2006 ident: 10.1002/pros.23007-BIB0020|pros23007-cit-0020 article-title: CXCL12/CXCR4 signalling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12 publication-title: Prostate doi: 10.1002/pros.20318 contributor: fullname: Chinni – volume: 119 start-page: 3917 issue: 17 year: 2012 ident: 10.1002/pros.23007-BIB0027|pros23007-cit-0027 article-title: A phase I/II study of chemosensitisation with the CXCR4 antagonist plerixafor in relapsed or refractory AML publication-title: Blood doi: 10.1182/blood-2011-10-383406 contributor: fullname: Uy – volume: 11 start-page: 17 year: 1999 ident: 10.1002/pros.23007-BIB0007|pros23007-cit-0007 article-title: Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion publication-title: Oncol Res contributor: fullname: Festuccia – volume: 8 start-page: 290 year: 2006 ident: 10.1002/pros.23007-BIB0021|pros23007-cit-0021 article-title: CXCR4 chemokine receptor mediates prostate tumour cell adhesion through alpha5 and beta3 integrins publication-title: Neoplasia doi: 10.1593/neo.05694 contributor: fullname: Engl – volume: 47 start-page: 2353 year: 2011 ident: 10.1002/pros.23007-BIB0025|pros23007-cit-0025 article-title: RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously downregulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways publication-title: Eur J Cancer doi: 10.1016/j.ejca.2011.05.006 contributor: fullname: Feng – volume: 42 start-page: 2838 year: 2006 ident: 10.1002/pros.23007-BIB0048|pros23007-cit-0048 article-title: Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells publication-title: Eur J Cancer doi: 10.1016/j.ejca.2006.06.024 contributor: fullname: Angelucci – volume: 18 start-page: 385 year: 2011 ident: 10.1002/pros.23007-BIB0052|pros23007-cit-0052 article-title: The TORC1/TORC2 inhibitor, Palomid 529, reduces tumour growth and sensitises to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells publication-title: Endocr Relat Cancer doi: 10.1530/ERC-11-0045 contributor: fullname: Gravina – volume: 18 start-page: 4440 year: 2011 ident: 10.1002/pros.23007-BIB0004|pros23007-cit-0004 article-title: Clinical trial update and novel therapeutic approaches for metastatic prostate cancer publication-title: Curr Med Chem doi: 10.2174/092986711797287539 contributor: fullname: Larsson – volume: 4 start-page: 291 year: 2004 ident: 10.1002/pros.23007-BIB0013|pros23007-cit-0013 article-title: The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis publication-title: J Exp Ther Oncol contributor: fullname: Arya – volume: 103 start-page: 700 year: 2012 ident: 10.1002/pros.23007-BIB0023|pros23007-cit-0023 article-title: Thromboxane A2 receptor signalling facilitates tumour colonisation through P-selectin-mediated interaction of tumour cells with platelets and endothelial cells publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2012.02200.x contributor: fullname: Matsui – volume: 14 start-page: 709 year: 2012 ident: 10.1002/pros.23007-BIB0028|pros23007-cit-0028 article-title: CXCR4 inhibition with AMD3100 sensitises prostate cancer to docetaxel chemotherapy publication-title: Neoplasia doi: 10.1593/neo.12324 contributor: fullname: Domanska – volume: 155 start-page: 231 year: 2009 ident: 10.1002/pros.23007-BIB0030|pros23007-cit-0030 article-title: A CXCR4 antagonist CTCE-9908 inhibits primary tumour growth and metastasis of breast cancer publication-title: J Surg Res doi: 10.1016/j.jss.2008.06.044 contributor: fullname: Huang – volume: 64 start-page: 8604 year: 2004 ident: 10.1002/pros.23007-BIB0011|pros23007-cit-0011 article-title: CXCR4 regulates growth of both primary and metastatic breast cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-1844 contributor: fullname: Smith – volume: 91 start-page: 902 year: 2012 ident: 10.1002/pros.23007-BIB0006|pros23007-cit-0006 article-title: Pathological roles of invadopodia in cancer invasion and metastasis publication-title: Eur J Cell Biol doi: 10.1016/j.ejcb.2012.04.005 contributor: fullname: Yamaguchi – volume: 6 start-page: 424 year: 2012 ident: 10.1002/pros.23007-BIB0005|pros23007-cit-0005 article-title: Occupy tissue: The movement in cancer metastasis publication-title: Cell Adh Migr doi: 10.4161/cam.21559 contributor: fullname: Bradbury – volume: 70 start-page: 9650 year: 2010 ident: 10.1002/pros.23007-BIB0059|pros23007-cit-0059 article-title: P53 status in stromal fibroblasts modulates tumour growth in an SDF1-dependent manner publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-1146 contributor: fullname: Addadi – volume: 155 start-page: 231 year: 2009 ident: 10.1002/pros.23007-BIB0064|pros23007-cit-0064 article-title: A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer publication-title: J Surg Res doi: 10.1016/j.jss.2008.06.044 contributor: fullname: Huang – volume: 69 start-page: 1460 year: 2009 ident: 10.1002/pros.23007-BIB0065|pros23007-cit-0065 article-title: Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth publication-title: Prostate doi: 10.1002/pros.21008 contributor: fullname: Porvasnik – volume: 182 start-page: 250 year: 2013 ident: 10.1002/pros.23007-BIB0029|pros23007-cit-0029 article-title: Effective inhibition of metastases and primary tumour growth with CTCE-9908 in oesophageal cancer publication-title: J Surg Res doi: 10.1016/j.jss.2012.09.035 contributor: fullname: Drenckhan |
SSID | ssj0010002 |
Score | 4.330188 |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 1227 |
Subtitle | CXCR4 Inhibition Has Anti-Tumor and Anti-Metastatic Effects in Prostate Cancer Models |
Title | CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dS-tAEF1qBfHlcvUqeq_KgD4Zok2aJuZR6hdiRcQrfSvZJNWAN5U2Eewf8g_cH-jMbLKJHw_Vl1C23U2zc5iZzZ45K8RO7Es_Gno-LkucwHRcaZkHkeWbEn0h7crZVkyFwr1L9-yvc97v9BuN_zXWUp7JvXD6aV3Jd6yKbWhXqpL9gmX1oNiAn9G-eEUL43UmG3f73WvHeCzUp5UPS9L7RDIPyxiTLGs8MeQoVZsEE_S5RsZTTUdHB1RNlISG5FIGSkQDZndwBVX-bzQ27nCRXtS-cQNJd2KHx1FGJCO-GzG8uCqJ-GNhPCbVAV1uyefsTOoJMMHyquhRcX-Cp0TVpp0SNzZNE-MirzhEPdIE4aOnFP-y-iKfJioNHj3oxlsOozyaHqR4rWF1NAW29H621zIxwnp1V60OWSkhadccr2UriYEiiGPW4n4aIJTgLM0MUeBbXhUGy63_d9FRcxaVvrM9oL4D7jsn5m3P7xCR9Ohai5bRhgnvXZUPoEVx7f3qvrU0qJbP3PwUP4qFCBwqVC2JRpwui4VeQbX4JV4YXPAGXFCBCwpwAYELECBA4AIFLqjABQpcIJ9BgwsYS6DAxX1r4AINLrwblOACBS6ogQsUuFbE7snxTffMLB8Up44FVAYfp7K9Kpop_t81AXan7UXD0MLA23KkjCSuSULPDSP3IAqGkbsutmcY8PdMv_ojFivsbYhmNs7jTUwyM7nFNn0F0_uPDg |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CXCR4+pharmacogical+inhibition+reduces+bone+and+soft+tissue+metastatic+burden+by+affecting+tumor+growth+and+tumorigenic+potential+in+prostate+cancer+preclinical+models&rft.jtitle=The+Prostate&rft.au=Gravina%2C+Giovanni+Luca&rft.au=Mancini%2C+Andrea&rft.au=Muzi%2C+Paola&rft.au=Ventura%2C+Luca&rft.date=2015-07-01&rft.issn=0270-4137&rft.volume=75&rft.issue=12&rft.spage=1227&rft.epage=1246&rft_id=info:doi/10.1002%2Fpros.23007&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_pros_23007 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-4137&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-4137&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-4137&client=summon |